Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
04/17/2003 | US20030073712 Antiinflamamtory agents; antiischemic agents |
04/17/2003 | US20030073704 Analgesics; antidiabetic agents; antiinflamamtory agents |
04/17/2003 | US20030073703 Autoimmune disease; antiinflammatory agents |
04/17/2003 | US20030073699 Compounds and methods to treat cardiac failure and other disorders |
04/17/2003 | US20030073685 Nitric oxide synthase inhibitor; antiinflammatory agents |
04/17/2003 | US20030073682 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
04/17/2003 | US20030073676 Dissolving in aqueous carrier; antiallergens |
04/17/2003 | US20030073669 N-heterocyclic derivatives as NOS inhibitors |
04/17/2003 | US20030073628 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
04/17/2003 | US20030073167 DNA encoding SNORF36 receptors |
04/17/2003 | US20030073076 Analyzing modulators or treatments of fibroproliferative diseases; obtain sample, incubate with modulator, monitor marker expression, decreased expression indicate effective modulator |
04/17/2003 | US20030072824 Having anti-oxidant, gastric mucosa injury inhibiting, aldose reductase inhibiting, blood glucose level elevation inhibiting action, platelet agglutination accelerating action, alcohol absorption inhibition, anti-inflammation properties |
04/17/2003 | US20030072756 Combination therapy using an IL-1 inhibitor and methotrexate |
04/17/2003 | US20030072753 Virus-like particles for the induction of autoantibodies |
04/17/2003 | US20030072747 Platelet-activating factor acetylhydrolase |
04/17/2003 | US20030072737 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
04/17/2003 | US20030072736 Human tumor necrosis factor receptor TR16 |
04/17/2003 | US20030070903 Systems, methods and apparatuses for manufacturing dosage forms |
04/17/2003 | CA2473970A1 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
04/17/2003 | CA2464662A1 Modulation of the expression of genes dependent on stat-1 |
04/17/2003 | CA2463507A1 Methods for the synthesis of substituted purines |
04/17/2003 | CA2463496A1 Method of obtaining an extract of ginger |
04/17/2003 | CA2463364A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors |
04/17/2003 | CA2463339A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
04/17/2003 | CA2463198A1 Pyrrolidinone derivatives |
04/17/2003 | CA2462950A1 3-[4-(substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2-indolinone derivatives as kinase inhibitors |
04/17/2003 | CA2462892A1 Human 3 relaxin |
04/17/2003 | CA2462881A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process |
04/17/2003 | CA2462876A1 Compositions for and methods of treating and preventing sirs/sepsis |
04/17/2003 | CA2462301A1 Para-amino benzoic acids as integrin antagonists |
04/17/2003 | CA2461435A1 Angiopoietin-2 specific binding agents |
04/17/2003 | CA2461343A1 Mammalian c-type lectins |
04/17/2003 | CA2461064A1 Inhibition of stat-1 |
04/17/2003 | CA2460480A1 Molecules for disease detection and treatment |
04/17/2003 | CA2460476A1 Protein modification and maintenance molecules |
04/17/2003 | CA2458645A1 Intracellular signaling molecules |
04/17/2003 | CA2458464A1 Monoclonal and cdr-grafted antibodies specific for human kdr |
04/16/2003 | WO2003032915A2 Viral inhibition by n-docosanol |
04/16/2003 | EP1302542A1 Novel physiologically active peptide and use thereof |
04/16/2003 | EP1302476A1 Reduced fk228 and use thereof |
04/16/2003 | EP1302461A1 Tnf-alpha production inhibitors |
04/16/2003 | EP1302201A1 Pharmaceutical composition improved in peroral absorbability |
04/16/2003 | EP1302115A1 Use of cystathionine |
04/16/2003 | EP1301598A2 Cell cycle proteins and mitosis-associated molecules |
04/16/2003 | EP1301595A2 G-protein coupled receptors |
04/16/2003 | EP1301539A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
04/16/2003 | EP1301535A2 G-protein coupled receptors |
04/16/2003 | EP1301534A2 Mutated pf-4, its fragments and mutated fusion peptides, their analogues, corresponding dna, cdna and mrna sequences and their use for inhibiting angiogenesis |
04/16/2003 | EP1301524A1 B7-like polynucleotides, polypeptides, and antibodies |
04/16/2003 | EP1301522A1 Novel compounds and methods |
04/16/2003 | EP1301517A1 Thienopyrrolidinones |
04/16/2003 | EP1301516A1 Modulators of protein tyrosine phosphatases (ptpases) |
04/16/2003 | EP1301514A1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
04/16/2003 | EP1301507A2 Mannich base prodrugs of 3 - (pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases |
04/16/2003 | EP1301506A1 Cyclic amino acid derivatives |
04/16/2003 | EP1301500A1 Nitrosated and nitrosylated taxanes, compositions and methods of use |
04/16/2003 | EP1301497A1 Colchinol derivatives as vascular damaging agents |
04/16/2003 | EP1301495A2 Inhibitors of copper-containing amine oxidases |
04/16/2003 | EP1301490A2 5-substituted 2-aryl-4-pyrimidinones |
04/16/2003 | EP1301488A1 Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists |
04/16/2003 | EP1301484A2 Capsaicin receptor ligands |
04/16/2003 | EP1301482A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
04/16/2003 | EP1301480A1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
04/16/2003 | EP1301472A2 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
04/16/2003 | EP1301211A2 Multifunctional nanodevice platform |
04/16/2003 | EP1301207A2 Compositions for treating bacterial infections, containing an oxazolidinone compound, sulbactam and and ampicillin |
04/16/2003 | EP1301203A1 Vaccine comprising active agent immunogenic acyl glyceryl phosphatidylinositol manno-oligosaccharide |
04/16/2003 | EP1301193A1 Process for preparing composition comprising medicinal herb extract for preventing and curing arthritis and composition thereof |
04/16/2003 | EP1301176A1 Method for coating solid particles with a thermofusible agent, and resulting coated solid particles |
04/16/2003 | EP1301173A1 A medicinal aerosol formulation |
04/16/2003 | EP1181047B1 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
04/16/2003 | EP1181017B1 Metalloprotease inhibitors |
04/16/2003 | EP1158967B1 Transdermal device comprising non-steroidal anti-inflammatory drugs incorporated in acrylic adhesive polymer matrix |
04/16/2003 | EP1086682B1 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of neurogenic inflammation |
04/16/2003 | EP1054667B1 Bicyclic pyrrole compounds, pharmaceutical compositions containing them and their use as antiinflammatory and immunomodulating agents |
04/16/2003 | EP1053240B1 Glucocorticoid-selective antiinflammatory agents |
04/16/2003 | EP1024807B1 Use of the compound 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamido acetate for the production of an anti-inflammatory drug with prevention of gastric hypersecretion and renal impairment |
04/16/2003 | EP1007505B1 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives |
04/16/2003 | EP0977565B1 Pharmaceutical composition comprising a tricyclic compound with enhanced stability, absorbability and low irritation potential |
04/16/2003 | EP0942896B1 Substituted phenols and thiophenols useful as antioxidant agents |
04/16/2003 | EP0920322B1 Use of modified autologous blood for the treatment of autoimmune diseases |
04/16/2003 | EP0912185B1 Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs |
04/16/2003 | EP0868522B1 Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them |
04/16/2003 | EP0824544B1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use |
04/16/2003 | EP0769958B1 Inhibitors of leukocyte adhesion |
04/16/2003 | EP0642356B1 Antibodies to p-selectin and their uses |
04/16/2003 | CN1411461A Thienopyridine derivatives and their preparing process and use |
04/16/2003 | CN1411458A Saccharin derivatives as orally active elastase inhibitors |
04/16/2003 | CN1411449A N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
04/16/2003 | CN1411447A Polymorphic crystalline forms of celecoxib |
04/16/2003 | CN1411446A Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
04/16/2003 | CN1411444A Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
04/16/2003 | CN1411440A Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
04/16/2003 | CN1411436A Hydroxamic acid derivative as inhibitor of formation of soluble human CD23 |
04/16/2003 | CN1411435A Novel use of phenyl hetero alkylamine derivatives |
04/16/2003 | CN1411373A Novel processes for making-and new crystalline form of-leflunomide |
04/16/2003 | CN1410536A Human source aprotinin gene, protein of said gene code and its application |
04/16/2003 | CN1410123A Chiese medicine preparation for treating parenchyma pain |
04/16/2003 | CN1410118A Chinese patent medicine for suppressing pain without habituation and its preparation method |
04/16/2003 | CN1410112A Fuyuan plaster for promoting blood circulation |